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Clinical epidemiology is alive and well in IndiaThis month we are extremely pleased to present a series
of articles written in collaboration with the International
Clinical Epidemiology Network (INCLEN) groups in India.
INCLEN is an international network of researchers that
support and strengthen clinical epidemiological research
in low and middle income countries. In 2007 an agreement
was signed between INCLEN and the Journal of Clinical
Epidemiology. Since then, the ties between the two organi-
zations have strengthened. This series, authored by mem-
bers of the India Clinical Epidemiology Units, is the
latest of the fruits of that collaboration. Because the core
function of the clinical epidemiology units in India is to de-
velop and promote evidence-based medicine, the articles
presented in this issue cover a wide variety of topics, in-
cluding the burden of illness, diagnosis, scale validation,
effectiveness, cost-effectiveness, the interpretation of evi-
dence, reporting guidelines, and knowledge translation.
The designs range from surveys, to case control studies,
to randomized studies. These are all applied in the context
of relevant clinical and community health problems seen in
India. See the overview and summary of the articles in-
cluded in the editorial by this month’s guest editor, Kurien
Thomas.
In other articles, Shiwa and colleagues investigated
whether the methodological quality is influenced by lan-
guage of publication in reports of randomized controlled
trials and controlled clinical trials of physiotherapy inter-
ventions in the Physiotherapy Evidence Database [PE-
Dro] scale. They assessed 13,392 reports of trials in
either English or another language. They found that al-
though English reports were more likely to have better
methodological quality than reports written in other lan-
guages, the magnitude of this influence was small. The
methodology used in this involved the use of total scores
of study quality, which is contentious, as is pointed out
by an accompanying commentary from da Costa et al.
Quality scales assess several criteria related to the de-
sign, conduct, and analysis of trials, and each earns
points that are aggregated into an overall score. The score
determines the classification of the study as one of the
higher or lower methodological quality, with the implica-
tion that bias has been prevented to a greater or lesser de-
gree. The authors argue that the PEDro database’s
inappropriate emphasis on the use of summary scores
from a quality scale likely introduces a bias into system-
atic reviews and meta-analyses when these scores are0895-4356  2013 Published by Elsevier Inc.
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Open access under CC BY-NC-ND licused as the main criteria on which the inclusion or exclu-
sion of trials is based. They recommend that the use of
summary scores be discouraged, and that the PEDro da-
tabase be restricted to presenting the scores for individual
items of the scale.
Although investigators are exhorted to optimize recruit-
ment by enhancing invitations to participate in registries
and studies by careful attention to readability, comprehen-
sion levels, layout, fonts, and use of visual material, the
success of this is rarely rigorously tested. Hall et al. con-
ducted a randomized trial to assess the effectiveness of
an ‘‘enhanced’’ invitation letter on increasing participation
in a cancer registry-based study. They found that the en-
hanced invitation letter was not effective in increasing par-
ticipation of cancer survivors; one area identified for
special attention in future studies is on tailoring techniques
to patient’s age.
The issue of unnecessary investigations in common
conditions is an ongoing challenge that is slowly being ad-
dressed through the use of clinical prediction rules [1]. It
is good to see this being tackled in the pediatric commu-
nity. Kulik and colleagues reviewed the systematically
identified clinical prediction rules for children with sus-
pected appendicitis and compared the rules’ methodo-
logical quality and performance. Although there were
a number of candidates, the authors found none of these
met their criteria, so modifications of the existing rules
or new rules are needed before they are adopted into rou-
tine clinical practice.
Systematic reviews can and should be used more often
to set research priorities. Maternal mortality is one of the
major problems identified in the Millennium Develop-
ment Goals; a targeted systematic approach is needed to
define the most promising research agenda. Chapman
et al. propose one approach - ‘‘evidence-mapping’’ of
the large number (178) of relevant reviews in the Co-
chrane database.
In a brief comment on the Strobe-ME statement [2],
Masse proposes to include more clinical laboratory scien-
tists in developing such guidelines.
Finally, the editorswant to express their gratitude to all the
reviewers who did such great work to help us in the past year
to both critically and constructively evaluate manuscripts
submitted to the Journal of Clinical Epidemiology. Without
their indispensable contributions, it would be impossible to
publish a journal of high quality that is increasingly moreense.
2 Editorials / Journal of Clinical Epidemiology 66 (2013) 1e2cited every year. We especially thank Drs Dorcas Beaton and
Andreas Lund, who, based on their excellent performance,
have been selected as reviewers of the year.
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